188 related articles for article (PubMed ID: 34990010)
1. Messenger RNA vaccine advances provide treatment possibilities for cancer: Several clinical trials are recruiting or underway to validate whether these vaccines will be effective in cancer treatment: Several clinical trials are recruiting or underway to validate whether these vaccines will be effective in cancer treatment.
Nierengarten MB
Cancer; 2022 Jan; 128(2):213-214. PubMed ID: 34990010
[No Abstract] [Full Text] [Related]
2. Cancer mRNA vaccines: clinical advances and future opportunities.
Sayour EJ; Boczkowski D; Mitchell DA; Nair SK
Nat Rev Clin Oncol; 2024 Jul; 21(7):489-500. PubMed ID: 38760500
[TBL] [Abstract][Full Text] [Related]
3. [New advances in clinical trials of cancer vaccines].
Peng F; Wei YQ
Ai Zheng; 2006 Aug; 25(8):1059-62. PubMed ID: 16965694
[TBL] [Abstract][Full Text] [Related]
4. Clinical advances and ongoing trials on mRNA vaccines for cancer treatment.
Lorentzen CL; Haanen JB; Met Ö; Svane IM
Lancet Oncol; 2022 Oct; 23(10):e450-e458. PubMed ID: 36174631
[TBL] [Abstract][Full Text] [Related]
5. TRICOM: enhanced vaccines as anticancer therapy.
Levy B; Panicalli D; Marshall J
Expert Rev Vaccines; 2004 Aug; 3(4):397-402. PubMed ID: 15270644
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer vaccines in clinical trials.
Lubaroff DM
Expert Rev Vaccines; 2012 Jul; 11(7):857-68. PubMed ID: 22913261
[TBL] [Abstract][Full Text] [Related]
7. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
8. From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape.
Chakraborty C; Sharma AR; Bhattacharya M; Lee SS
Front Immunol; 2021; 12():679344. PubMed ID: 34305909
[TBL] [Abstract][Full Text] [Related]
9. Carcinoembryonic antigen as a target for cancer vaccines.
Hodge JW
Cancer Immunol Immunother; 1996 Nov; 43(3):127-34. PubMed ID: 9001565
[TBL] [Abstract][Full Text] [Related]
10. Cellular vaccine therapies for cancer.
Mastrangelo MJ; Sato T; Lattime EC; Maguire HC; Berd D
Cancer Treat Res; 1998; 94():35-50. PubMed ID: 9587681
[No Abstract] [Full Text] [Related]
11. Developing recombinant and synthetic vaccines for the treatment of melanoma.
Restifo NP; Rosenberg SA
Curr Opin Oncol; 1999 Jan; 11(1):50-7. PubMed ID: 9914879
[TBL] [Abstract][Full Text] [Related]
12. Rekindling cancer vaccines.
Branca MA
Nat Biotechnol; 2016 Oct; 34(10):1019-1024. PubMed ID: 27727216
[No Abstract] [Full Text] [Related]
13. Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities.
Wang B; Pei J; Xu S; Liu J; Yu J
Front Immunol; 2023; 14():1246682. PubMed ID: 37744371
[TBL] [Abstract][Full Text] [Related]
14. Immunological therapy of human tumors by gene-modified cellular vaccines.
Parmiani G
Folia Biol (Praha); 2000; 46(6):207-9. PubMed ID: 11140852
[No Abstract] [Full Text] [Related]
15. Improved peptide vaccine strategies, creating synthetic artificial infections to maximize immune efficacy.
van der Burg SH; Bijker MS; Welters MJ; Offringa R; Melief CJ
Adv Drug Deliv Rev; 2006 Oct; 58(8):916-30. PubMed ID: 16979788
[TBL] [Abstract][Full Text] [Related]
16. Next-generation peptide vaccines for advanced cancer.
Yamada A; Sasada T; Noguchi M; Itoh K
Cancer Sci; 2013 Jan; 104(1):15-21. PubMed ID: 23107418
[TBL] [Abstract][Full Text] [Related]
17. Technical challenges facing therapeutic cancer vaccines.
Ward S; Copier J; Dalgleish A
Curr Opin Drug Discov Devel; 2008 Mar; 11(2):168-77. PubMed ID: 18283604
[TBL] [Abstract][Full Text] [Related]
18. Personalized pancreatic cancer therapy: from the perspective of mRNA vaccine.
Huang X; Zhang G; Tang TY; Gao X; Liang TB
Mil Med Res; 2022 Oct; 9(1):53. PubMed ID: 36224645
[TBL] [Abstract][Full Text] [Related]
19. The role of immunotherapy in the treatment of colorectal cancer.
Reddy GK
Clin Colorectal Cancer; 2006 Jan; 5(5):324-6. PubMed ID: 16512990
[No Abstract] [Full Text] [Related]
20. Don't blame the messenger: lessons learned for cancer mRNA vaccines during the COVID-19 pandemic.
Morris VK; Kopetz S
Nat Rev Cancer; 2022 Jun; 22(6):317-318. PubMed ID: 35277674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]